NR4A1表达异常有助于胃癌的放射治疗耐药性
Peidong Ni1, Shiyang Dong2, Guozhong Yao3
1Department of General Surgery, Xuzhou Central Hospital, Affiliated Hospital of Southeast University, Xuzhou, Jiangsu Province, P.R. China.
Scientific reports
|October 17, 2025
概括
这项研究发现,减少NR4A1基因表达与胃癌 (GC) 中的放射治疗耐药性有关. 恢复NR4A1水平增加了癌细胞对辐射的敏感性,这表明NR4A1是GC的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 放射治疗研究 放射治疗研究
背景情况:
- 胃癌 (GC) 是一个重要的全球健康问题,经常在晚期被诊断出来.
- 放射治疗耐药性是一个主要的挑战,限制了GC患者的治疗疗效.
- 识别影响放射电阻的遗传因素对于开发改进的治疗策略至关重要.
研究的目的:
- 在胃癌中识别与放射治疗耐药性相关的基因.
- 为了研究NR4A1在GC电阻中的作用.
- 评估NR4A1作为GC治疗标的临床相关性.
主要方法:
- 高通量测序和定量逆转录-聚合酶链反应 (qRT-PCR) 用于分析基因表达.
- 功能性研究涉及NR4A1过度表达在GC细胞系 (MKN45-R,AGS-R) 和其父细胞系.
- 在体内动物模型中评估NR4A1对GC生长,转移和对辐射 (IR) 的反应的临床影响.
主要成果:
- 与父细胞相比,耐辐射GC细胞 (MKN45-R,AGS-R) 中NR4A1的表达显著下降.
- 在抗辐射GC细胞中,NR4A1的过度表达增加了它们对辐射的敏感性.
- 过度表达NR4A1抑制了受辐射GC动物模型中的瘤生长和转移.
结论:
- 在胃癌中,NR4A1在克服放射治疗耐药性的过程中起着至关重要的作用.
- NR4A1增强了胃癌细胞对放射治疗的敏感性.
- NR4A1代表了一种有前途的治疗标,用于改善GC的放射治疗结果.
相关概念视频
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
02:23Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K